Evidence map›Paper›PMID 27785374›Full record

ArticleJournal of drug assessment2016

Montelukast in the treatment of perennial allergic rhinitis in paediatric Japanese patients; an open-label clinical trial.

Kimihiro Okubo, Yoichi Inoue, Hirotaka Numaguchi, Kumi Tanaka, Itori Saito, Nobuyuki Oshima, Yuki Matsumoto, Marita Prohn, Anish Mehta, Chisato Nishida and 1 more

Registry-linked trialOpen access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of drug assessment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01852812 (A Phase III, Open-Label Clinical Trial to Study the Safety and Pharmacokinetics of MK-0476 in Japanese Pediatric Subjects Aged 1 to 15 Years Old With Perennial Allergic Rhinitis), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01852812 phase3completednot on this map

A Phase III, Open-Label Clinical Trial to Study the Safety and Pharmacokinetics of MK-0476 in Japanese Pediatric Subjects Aged 1 to 15 Years Old With Perennial Allergic Rhinitis

TypeinterventionalSponsorOrganon and CoRan2013 to 2013Enrolled87ConditionsPerennial Allergic RhinitisArmsMontelukast Oral Granules (OG), Montelukast Chewable Tablets (CT)
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Kimihiro OkuboDepartment of Otorhinolaryngology, Nippon Medical School Hospital , Tokyo , Japan.
Yoichi InoueMSD KK , Tokyo , Japan.
Hirotaka NumaguchiMSD KK , Tokyo , Japan.
Kumi TanakaMSD KK , Tokyo , Japan.
Itori SaitoMSD KK , Tokyo , Japan.
Nobuyuki OshimaMSD KK , Tokyo , Japan.
Yuki MatsumotoMSD KK , Tokyo , Japan.
Marita ProhnMSD , Oss , The Netherlands.
Anish MehtaMerck & Co. Inc. , Kenilworth , NJ , USA.
Chisato NishidaMSD KK , Tokyo , Japan.
George PhilipMerck & Co. Inc. , Kenilworth , NJ , USA.
MSD K.K. (Japan) · JPMerck & Co., Inc., Rahway, NJ, USA (United States) · USMSD (Netherlands) · NLNippon Medical School Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

allergicAsian continental ancestry groupleukotriene antagonistsleukotrienespaediatricsperennialrhinitis

Identifiers

PMID27785374
PMCPMC5040008
OpenAlexW2495151691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.